Cardiome Pharma (CRME) Misses Q1 EPS by 5c

Cardiome Pharma (NASDAQ: CRME) reported Q1 EPS of ($0.20), $0.05 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $6.92 million.

For earnings history and earnings-related data on Cardiome Pharma (CRME) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c